Cao Yanming, Liu Xunzhi, Xu Haibo
Department of Orthopaedics, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, P. R. China.
Clin Lab. 2012;58(7-8):845-50.
The goal was to find out the clinical significances of tartrate-resistant acid phosphatase isoform 5b (TRACP 5b), a biomarker of bone resorption, and bone alkaline phosphatase (BAP) and osteocalcin, two markers of bone formation, in evaluating the osteoporotic fracture risk in Chinese patients.
Thirty six Chinese osteoporotic fracture patients and 32 Chinese healthy subjects were included in the study. Bone mineral density (BMD) of lumbar spine and total body were determined by dual-energy X-ray absorptiometry in all subjects. Fasting blood samples were collected from all subjects and the serum concentrations of TRACP 5b, BAP, and osteocalcin were analyzed with enzyme-linked immunosorbent assay or immunoradiometric assay.
With lower BMD, the osteoporotic fracture patients had elevated levels of TRACP 5b and BAP, compared with the healthy controls. No difference in serum osteocalcin level was observed between the fracture patients and the control.
Elevated serum TRACP 5b and BAP, combined with or without increased osteocalcin, are valuable tools for the assessment of osteoporotic fracture risk in Chinese patients.
目的是探究抗酒石酸酸性磷酸酶同工型5b(TRACP 5b,一种骨吸收生物标志物)以及骨碱性磷酸酶(BAP)和骨钙素(两种骨形成标志物)在中国患者骨质疏松性骨折风险评估中的临床意义。
本研究纳入了36例中国骨质疏松性骨折患者和32例中国健康受试者。所有受试者均采用双能X线吸收法测定腰椎和全身的骨密度。采集所有受试者的空腹血样,采用酶联免疫吸附测定法或免疫放射测定法分析血清中TRACP 5b、BAP和骨钙素的浓度。
与健康对照组相比,骨质疏松性骨折患者骨密度较低,其TRACP 5b和BAP水平升高。骨折患者与对照组之间血清骨钙素水平未观察到差异。
血清TRACP 5b和BAP升高,无论骨钙素是否升高,都是评估中国患者骨质疏松性骨折风险的有价值工具。